SRC and cancer: Altogether, our work along with these other studies revealing the requirement of PI3K signalling in tumourigenesis in Drosophila models, suggests that targeting PI3K signalling might provide a novel therapeutic approach for Src-overexpressing or polarity-impaired Ras-driven cancers.